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he endoplasmic reticulum (ER) maintains an envi-
ronment essential for secretory protein folding.
Consequently, the premature transport of polypep-
tides would be harmful to the cell. To avert this scenario,
mechanisms collectively termed “ER quality control” pre-
vent the transport of nascent polypeptides until they
properly fold. Irreversibly misfolded molecules are sorted
for disposal by the ER-associated degradation (ERAD)
pathway. To better understand the relationship between
quality control and ERAD, we studied a new misfolded
T
 
variant of carboxypeptidase Y (CPY). The molecule was
recognized and retained by ER quality control but failed
to enter the ERAD pathway. Systematic analysis revealed
that a single, speciﬁc N-linked glycan of CPY was re-
quired for sorting into the pathway. The determinant is de-
pendent on the putative lectin-like receptor Htm1/Mnl1p.
The discovery of a similar signal in misfolded proteinase A
supported the generality of the mechanism. These studies
show that speciﬁc signals embedded in glycoproteins can
direct their degradation if they fail to fold.
 
Introduction
 
The maturation of newly synthesized proteins entering the secre-
tory pathway is monitored by mechanisms collectively termed
ER quality control (for reviews see Ellgaard and Helenius, 2003;
McCracken and Brodsky, 2003; Trombetta and Parodi, 2003).
Proteins in the midst of folding are retained in the ER until the
process is completed. Irreversibly misfolded species are sorted
from normal proteins and targeted for degradation. Because ab-
errant proteins are not benign, elimination provides the most
effective means of abrogating potential toxicity. The best-
described route is the ER-associated degradation (ERAD) path-
way, with its basic tenets conserved among all eukaryotes. In
ERAD, misfolded proteins are translocated from the ER lumen to
the cytosol (termed “dislocation”), most likely through a pore com-
plex composed of Sec61 subunits and/or Der1p (Pilon et al., 1997;
Plemper et al., 1999; Lilley and Ploegh, 2004; Ye et al., 2004).
On the cytosolic side, the substrate is ubiquitylated by ER local-
ized ubiquitin conjugating enzymes and ligases. The driving
force for substrate extraction from the ER comes from the AAA-
ATPase Cdc48p/Ufd1p/Npl4p complex (Shamu et al., 2001; Ye
et al., 2001; Jarosch et al., 2002). Finally, the substrate is degly-
cosylated by protein 
 
N
 
-glycanase (if applicable) and degraded by
the 26S proteasome (Suzuki et al., 2000; Hirsch et al., 2003).
The upstream events of substrate sorting and targeting to
the translocation pore are less clear. In higher eukaryotes, fold-
ing and quality control functions of glycoprotein synthesis are
integrated within the calnexin/calreticulin lectin cycle. A third
ER lectin, EDEM (Htm1/Mnl1p in yeast), is used to direct mis-
folded proteins off-cycle and into the ERAD pathway (Moli-
nari et al., 2003; Oda et al., 2003). The mechanism is not uni-
versal because many proteins (e.g., nonglycosylated) use other
pathways that are less defined. In budding yeast, the process is
murkier with the absence of a typical calnexin/calreticulin cycle.
However, the requirement of Htm1/Mnlp for ERAD reflects its
functional conservation and emphasizes that general strategies
of protein quality control are shared among all eukaryotes
(Jakob et al., 2001; Nakatsukasa et al., 2001).
The determinants used for sorting and targeting sub-
strates have not been fully characterized. At first glance, tack-
ling the problem seems simple. However, the range of possi-
ble substrates illustrates the enormity of the task. Trafficking
through the ER includes soluble proteins, single and multi-span-
ning integral membrane proteins, and lipid anchored proteins.
For their maturation, additional steps may include glycosylation,
prolyl hydroxylation, disulfide bond formation, and assembly
into complex oligomers. Within this backdrop is the vast num-
ber of conformations and configurations that the cell must de-
termine are unfolded (in the process of folding), folded, and
misfolded. Although the prevailing evidence indicates that
chaperones recognize and bind unfolded and misfolded pro-
teins, how the cell arrives at the decision to degrade individual
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molecules remains unknown. Defining the nature of substrate
determinants is key to this understanding.
Previously, we reported that cytosolic and lumenal sur-
veillance mechanisms coexist to monitor the range of proteins
trafficking through the ER (Vashist and Ng, 2004). Because the
pathways converge at the ubiquitylation/degradation step of
ERAD, they were designated ERAD-C (cytosolic) and ERAD-L
(lumenal). In this study, we focused our attention on glycopro-
tein substrates of ERAD-L. By systematically analyzing a se-
ries of substrate variants, we discovered that determinants used
for sorting/retention (from folded proteins) could be distin-
guished from those used to target substrates to ERAD. Initially,
the unfolded polypeptide alone suffices for efficient substrate
recognition and retention. The decision to terminate the mole-
cule, however, requires an additional structural determinant
embedded in the substrate.
 
Results
 
CPY
 
 
 
1, a misfolded protein variant 
recognized and retained by ER quality 
control but not by ERAD
 
The most extensively studied model ERAD substrate is CPY*,
a mutant of the vacuolar protease carboxypeptidase Y (CPY).
CPY* is a product of the 
 
prc1-1
 
 allele (glycine to arginine re-
placement at position 255) that misfolds irreversibly (Finger et
al., 1993). To extend its versatility, we intended to create a
substrate that permitted simultaneous monitoring of endoge-
nous CPY as an internal control for secretory function and gel
loading. A CPY variant designated CPY
 
 
 
1 was constructed
that differs by a 154–amino acid deletion near the COOH ter-
minus and migrates distinctly on SDS gels (Fig. 1, A and B).
Guided by the crystal structure, we predicted that the deletion
would disrupt folding due to the extensive loss of intramolecu-
lar interactions (Endrizzi et al., 1994). Three lines of evidence
supported this view.
By pulse-chase analysis, CPY
 
 
 
1 was not modified by com-
partmentalized enzymes that report on the transit state of CPY
(Fig. 1 B). This result suggested that CPY
 
 
 
1 might be recognized
and retained by ER quality control. Cell localization experiments
confirmed this notion. As visualized by indirect immunofluores-
cence, CPY
 
 
 
1 accumulated intracellularly at sites precisely coin-
cident with the ER marker Kar2p (Fig. 1 C; Normington et al.,
1989; Rose et al., 1989). Correspondingly, this pattern was indis-
tinguishable to that observed for CPY* (Fig. 1 C). We next tested
whether CPY
 
 
 
1 expression activates the unfolded protein re-
sponse (UPR). The UPR is an ER-to-nucleus signal transduction
pathway sensitive to the presence of misfolded proteins the ER
lumen (for reviews see Patil and Walter, 2001; Spear and Ng,
2001; Rutkowski and Kaufman, 2004). By monitoring the activ-
ity of the UPR-specific reporter gene 
 
UPRE-LacZ 
 
(Cox et al.,
1993), cells expressing CPY
 
 
 
1 activated the UPR to the same
extent as cells expressing CPY* (Fig. 1 D). Together, these ex-
periments demonstrated that CPY
 
 
 
1 is a bona fide misfolded
protein recognized by ER quality control and the UPR.
Unexpectedly, metabolic pulse-chase experiments showed
that CPY
 
 
 
1 turned over poorly by comparison to CPY* (Fig. 1,
Figure 1. CPY 1 is a misfolded protein recognized by ER quality control
but poorly degraded by ERAD. (A) Schematic representation of CPY,
CPY*, and CPY 1. Carbohydrates are represented by branched symbols,
asterisk indicates the CPY* G255R mutation, dark gray boxes indicate
signal sequences, and light gray boxes represent HA-epitope tags. (B)
CPY 1 remains unmodified by Golgi and vacuolar enzymes. Wild-type
cells expressing CPY 1 (pES57) were pulsed labeled for 10 min and
chased for 0 (lane P) or 30 min (lane C). Immunoprecipitated CPY and
CPY 1 were resolved by SDS-PAGE and visualized by autoradiography.
CPY 1, ER proCPY (p1), Golgi carbohydrate-modified proCPY (p2), and
vacuolar protease-processed mature CPY (m) are indicated. (C) Intracellu-
lar localization of CPY 1. CPY* and CPY 1 were localized by indirect
immunofluorescence as described in Materials and methods (C, panels a
and c, respectively). Simultaneous localization of Kar2p was performed as
a marker of the ER (C, panels b and d). (D) CPY 1 induces the UPR. Wild-
type cells carrying an integrated UPRE-LacZ reporter gene (ESY39) and
expressing HA epitope-tagged CPY, CPY*, or CPY 1 were assayed for
 -galactosidase activity. The data reflect three independent experiments
with the SD of the mean indicated. (E) Wild-type and  cue1 cells express-
ing CPY* were pulse labeled for 10 min and chased for the times indi-
cated. CPY* was immunoprecipitated from detergent lysates and resolved
by SDS-PAGE. CPY* decay was quantified by phosphorimager analysis
and plotted to the right of autoradiograms. The data reflect three indepen-
dent experiments with the SD of the mean indicated. (F) Wild-type and
 cue1 cells expressing CPY 1 were analyzed by pulse-chase analysis as
described in E. 
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compare E with F). This indicated that CPY
 
 
 
1, though retained
by ER quality control, is a poor substrate for ERAD. This
view was confirmed by its failure to be further stabilized in the
 
 
 
cue1
 
 ERAD mutant (Fig. 1 F). Cue1p is a critical component
for CPY* degradation as it anchors the ubiquitin conjugating
enzyme Ubc7p to the ER membrane (Biederer et al., 1997). The
residual turnover was likely through alternative pathways that
degrade misfolded proteins when ERAD is disrupted or satu-
rated (Haynes et al., 2002; Spear and Ng, 2003). Together, the
data show that ER quality control and ERAD are mechanisms
that can be uncoupled at the substrate level. This raised the in-
triguing possibility that ER retention and entry into ERAD use
distinct substrate determinants.
Nonetheless, we envisioned other equally plausible ex-
planations that could account for CPY
 
 
 
1’s unusual behavior.
Because the deletion is large, the severity of the lesion might
increase the tendency of the remaining polypeptide to ag-
gregate. Substrate solubility is an important prerequisite for
ERAD. CPY* aggregates caused by faulty chaperone function
were shown to degrade inefficiently (Nishikawa et al., 2001).
To determine whether aggregate formation contributes to
CPY
 
 
 
1 stability, microsomal membranes containing CPY* or
CPY
 
 
 
1 were prepared from logarithmically growing cells. The
membranes were solubilized in nonionic detergent under phys-
iological conditions and subjected to centrifugation. Under
these conditions, large protein aggregates sediment rapidly and
separate from soluble proteins remaining in the supernatant.
Detergent-insoluble (pellet) and detergent-soluble (superna-
tant) fractions were collected, proteins resolved by SDS-
PAGE, and analyzed by immunoblotting. To control for the
procedure, we specifically generated CPY* aggregates from
cells severely limiting for ER chaperones (
 
 
 
ire1
 
; Spear and
Ng, 2003). This species was analyzed in parallel. As shown in
Fig. 2, CPY* and CPY
 
 
 
1 were both recovered entirely from
the supernatant fraction (B and C), whereas CPY* aggregates
from 
 
 
 
ire1
 
 cells were found predominantly in the pellet frac-
tion (A). In every case, the ER integral membrane protein
Sec61p was recovered from the soluble fraction showing that
membranes were completely solubilized. This experiment
showed that the formation of detergent-insoluble aggregates
was not a root cause of the CPY
 
 
 
1 ERAD defect. Furthermore,
CPY
 
 
 
1 puncta, which would be characteristic of intracellular
aggregates, were never observed in immunolocalization experi-
ments (DePace et al., 1998). Instead, CPY
 
 
 
1 was always found
to be evenly distributed throughout the ER in patterns indistin-
guishable from CPY* and Kar2p (Fig. 1 C).
We next tested a second possibility. Inspection of the
CPY
 
 
 
1 sequence revealed a striking consequence of the dele-
tion. A lysine rich domain was eliminated, leaving behind a
116–amino acid stretch devoid of lysines at the COOH termi-
nus. Because CPY* ubiquitylation is required for its disloca-
tion (Shamu et al., 2001; Jarosch et al., 2002), we wondered
whether loss of putative ubiquitylation sites crucial for ERAD
could explain the defect. To test the possibility, nine lysine
residues corresponding to the CPY
 
 
 
1 deleted region were
changed to arginine in full-length CPY*. The resulting mole-
cule, K(9)R-CPY*, was degraded as efficiently as CPY* dem-
onstrating that the COOH-terminal lysines are not required for
ERAD (Fig. 3 A). Conversely, the addition of lysine residues to
the COOH-terminal domain of CPY
 
 
 
1 failed to destabilize it
(Fig. 3 B). Together, these data show that the COOH-terminal
lysine residues of CPY do not constitute critical determinants
for its turnover by ERAD.
 
A context-dependent glycan signal for 
ERAD
 
Another outcome of the CPY
 
 
 
1 deletion was the elimination
of the N-linked glycosylation site nearest the COOH terminus
(Fig. 4 A, glycan D). Because CPY
 
 
 
1 retains three other
N-linked glycans (Fig. 4 A, sites A–C), it was not apparent how
its loss alone could so severely disrupt ERAD. To test whether
the carbohydrate is a critical determinant, a CPY* glycan D
mutant (Fig. 4 A, ABCd-CPY*) was created and its turnover
analyzed. Indeed, ABCd-CPY* was degraded poorly compared
with CPY* (Fig. 4 C). This result showed that glycan D is an
important determinant of CPY* degradation and explains, at
least in part, why CPY
 
 
 
1 is not a substrate for ERAD.
In considering glycan D’s role in ERAD, three potential
mechanisms were formulated to explain its requirement. The
first envisions a carbohydrate threshold that demands a mini-
mum number for each substrate. This requirement could be re-
lated to molecular weight, with the similarly sized CPY* and
Figure 2. CPY 1 does not form detergent insoluble aggregates. Mi-
crosomes were prepared from  ire1 cells overexpressing CPY* (A), wild-
type cells expressing CPY* (B), and wild-type cell expressing CPY 1 (C).
Membranes were solubilized in 1% Triton X-100 and separated into pellet
and supernatant fractions by centrifugation at 100,000 g. Detergent-soluble
(S), detergent-insoluble (P), and total (T) fractions were resolved by SDS-
PAGE, followed by immunoblotting to detect CPY* and CPY 1 using anti-
HA antibodies. The extent of membrane solubilization was determined by
reprobing blots for Sec61p, an integral membrane protein control. Asterisks
indicate underglycosylated and cytosolic CPY* that form when overex-
pressed in  ire1 cells (Spear and Ng, 2003). 
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KHN (misfolded simian virus 5 HA-neuramindase) substrates
requiring four glycans, whereas the smaller PrA* (misfolded
proteinase A) requires only two (Finger et al., 1993; Vashist et
al., 2001). The second is a positional model that requires a car-
bohydrate at a fixed point in the polypeptide, perhaps as a “mo-
lecular handle” to orient its transfer to the translocon after lec-
tin binding. In line with this view, both KHN and PrA* contain
glycosylation sites at roughly the same position to their COOH
termini as glycan D of CPY*. For the first two models, the pro-
tein content apart from maintaining glycosylation site(s) is ir-
relevant. In the third model, glycan D forms part of an ERAD-
specific signal that is recognized only when the protein is un-
folded. Here, the signal would be comprised of the carbohy-
drate and a protein determinant. The last model is compatible
with a wider range of proteins because it requires only a single
carbohydrate and no positional requirement.
To distinguish the models, we generated the remaining
CPY* single-site glycosylation mutants to test if ERAD effi-
ciency is related to carbohydrate density. By contrast to the D
glycan, eliminating any of the other three carbohydrates had no
effect on CPY* degradation (Fig. 4 C). These data show that
only glycan D is essential for efficient degradation of mis-
folded CPY and rule out the notion of a carbohydrate threshold.
The findings were intriguing because Htm1/Mnl1p was
proposed to be an ERAD-specific lectin (Jakob et al., 2001;
Nakatsukasa et al., 2001). However, little was known regarding
how it recognizes substrate. If Htm1/Mnl1p acts specifically
through glycan D, the stability of ABCd-CPY*, which bears
the other three glycans, should be unaffected in cells lacking
 
HTM1/MNL1
 
. To test the assertion, we measured CPY* and
ABCd-CPY* turnover in wild-type and 
 
 
 
htm1/mnl1
 
 cells.
In metabolic pulse-chase experiments, CPY* degradation was
dependent on 
 
HTM1/MNL1
 
 as previously reported (Fig. 4 D;
Jakob et al., 2001; Nakatsukasa et al., 2001). By contrast,
ABCd-CPY* was degraded poorly in wild-type cells with no
further stabilization in the 
 
 
 
htm1/mnl1
 
 cells (Fig. 4 E). Inter-
estingly, the residual degradation of ABCd-CPY* in the pres-
ence or absence of Htm1/mnl1p required Cue1p (Fig. 4 E).
This likely reflects a lectin-independent mode of ERAD re-
vealed only upon simultaneous disruption of the lectin and its
substrate determinant. We next assessed whether glycan D is
sufficient to direct CPY* to ERAD in an Htm1/Mnl1p-depen-
dent manner. For this, a mutant variant glycosylated only at site D
was constructed (abcD-CPY*). When expressed in wild-type
cells, abcD-CPY* was degraded efficiently (Fig. 4 F). In
 
 
 
htm1/mnl1
 
 cells, however, abcD-CPY* was stabilized to the
same extent as CPY* (Fig. 4 F). Together, these data show that
a single, specific carbohydrate is necessary and sufficient in
directing substrate into ERAD by way of Htm1/Mnl1p.
We wondered if the specificity of the glycan was unique
to CPY* or a general feature of lectin-dependent ERAD. For
this, we analyzed the ERAD substrate PrA* (Finger et al.,
1993). PrA* is a mutant version of the endogenous vacuolar en-
zyme, proteinase A. PrA* contains two N-linked glycans, one
near its NH
 
2
 
 terminus and the other near the COOH terminus at
a position similar to CPY*’s glycan D. Each site was disrupted
singly by replacing asparagine codons with glutamine. The mu-
tant variants, Ab-PrA* and aB-PrA* (Fig. 5 A, follows the no-
menclature of CPY* glycan mutants), were expressed in wild-
type cells (deleted of endogenous 
 
PEP4
 
 gene for detection of
PrA*) and their turnover measured. As shown in Fig. 6, the
Ab-PrA* was degraded indistinguishably from PrA*. Because
Figure 3. COOH-terminal lysines are not required for
CPY* degradation. (A) CPY* (pDN436) or K(9)R CPY*
(pES115) degradation in wild-type cells was determined
by pulse-chase analysis performed in Fig. 1 E. (B) Turn-
over of CPY 1 (pES57) or R(3)K CPY 1 (pES95) was
determined using wild-type cells as in A. Plots reflect two
independent experiments with the SD of the mean indicated. 
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PrA* is glycosylated at only two sites, its degradation depends
on a single, specific glycan signal like CPY* or is carbohydrate
independent. The question was answer by the results of two ex-
periments. First, Ab-PrA* degradation is dependent on Htm1/
Mnl1p to a similar extent as PrA* (Fig. 6, A and B). Second,
turnover of reciprocal mutant, aB-PrA*, was strongly defective
and little affected by the loss of Htm1/Mnl1p (Fig. 6 C). These
data support the idea that single ERAD glycan determinants are
preembedded in glycoproteins. However, a wider range of sub-
strates must be tested to determine whether other configura-
tions are used. Serendipitously, analysis of the PrA* model also
ruled out COOH-terminal positioning being a requirement be-
cause its sole determinant is closer to the NH
 
2
 
 terminus.
Together, these data show that determinants for recogni-
tion and retention of misfolded proteins are distinct from sig-
nals used for targeting to the ERAD pathway. For entry into the
Htm1/Mnl1p-dependent arm of ERAD, specific N-linked gly-
cans preencoded in glycoproteins form essential determinants.
The signals are not positionally constrained but are neverthe-
less context dependent because glycans at other positions can-
not substitute.
 
Discussion
 
Cells deploy an array of mechanisms devoted to the detection
and disposal of aberrant proteins. In the secretory pathway,
checkpoints posted at the ER, Golgi apparatus, and plasma
membrane monitor the state of newly synthesized proteins and
the integrity of folded proteins (Arvan et al., 2002; Ellgaard
and Helenius, 2003). Irreversibly misfolded proteins detected
at any of these sites are sorted and targeted for degradation. In
the ER, multiple quality control pathways are needed to moni-
tor the topologically diverse molecules that traffic through the
organelle. Two distinct pathways, acting as sequential check-
points, were previously defined through analysis of their client
substrates (Vashist and Ng, 2004). The first, termed ERAD-C
monitors the cytosolic domains of membrane proteins. Mem-
brane proteins passing the ERAD-C checkpoint and all soluble
proteins are next examined by ERAD-L. Molecules with lume-
nal lesions are retained and degraded.
Misfolded proteins recognized by ERQC are not always
inevitably degraded by ERAD. Among a group of misfolded
Ste6p mutants retained in the ER, some variants are degraded
by ERAD, whereas others are stable (Loayza et al., 1998). Al-
 
designate mutant sites. (B) CPY* and mutant variants were pulse labeled
for 10 min, immunoprecipitated, and treated (or mock treated) with Endo
H to remove N-linked oligosaccharides. Proteins were resolved by SDS-
PAGE and visualized by autoradiography. Positions of CPY*, 
 
 
 
1 CPY*
(altered at one of four glycosylation sites), 
 
 
 
4 CPY* (all four glycosylation
sites altered), and deglycosylated CPY* are indicated. (C) Degradation of
CPY* glycosylation mutants analyzed by metabolic pulse chase. Cells
were pulse labeled for 10 min with [
 
35
 
S]methionine/cysteine and chase
for times indicated. Proteins were resolved by SDS-PAGE and quantified
by phosphorimager analysis. The data reflect two independent experi-
ments with the SD of the mean indicated. Representative autoradiograms
are shown for each experiment. (D–F) Turnover of CPY* glycosylation
mutants in wild-type and 
 
 
 
htm1/mnl1
 
 cells performed as in C. ABCd-CPY*
turnover was also analyzed in 
 
 
 
cue1
 
 cells for comparison (E).
Figure 4.
 
A single, specific N-linked oligosaccharide is required for CPY*
degradation.
 
 (A) Schematic representation of CPY* N-linked glycosylation
mutants. Glycans at positions 124, 198, 279, and 479, are denoted by
the upper case letters A, B, C, and D, respectively. Lower case letters 
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though the reasons for the difference are unknown, these stud-
ies demonstrated that retention and degradation are separable
mechanisms. In the ERAD-L system, the theme is similar. Al-
though both CPY* and CPY
 
 
 
1 are retained by ERQC, only
CPY* is degraded efficiently by ERAD (Fig. 1). Through sys-
tematic analysis of these substrates, we discovered that the de-
leted glycan of CPY
 
 
 
1 is a critical determinant for targeting
CPY to ERAD when misfolded. Subsequent analysis using
PrA* revealed an analogous signal demonstrating the generality
of the mechanism. In either case, the determinant is used exclu-
sively as other glycans naturally positioned along the molecules
cannot substitute. By contrast, ERAD-C substrates are degraded
independent of glycosylation state (Vashist and Ng, 2004).
N-linked carbohydrates perform many functions and their
participation in ERQC is well established. In higher eukaryotes,
a subset of glycoproteins relies on the ER lectins calnexin and
calreticulin for folding (for reviews see Ellgaard and Helen-
ius, 2003; Sitia and Braakman, 2003). They work by binding
trimmed, monoglucosylated N-linked glycans of newly synthe-
sized proteins and provide a platform for the participation of ac-
cessory folding enzymes. Removal of the remaining glucose res-
idue by glucosidase II frees the substrate from the lectin. Should
the substrate remain unfolded, UDP-glucose/glycoprotein glu-
cosyltransferase (GT) reglucosylates the glycan for another round
of lectin binding. In this mode, GT is the folding sensor and sub-
strates remaining in the cycle are retained in the ER as a conse-
quence. Proteins that cannot fold properly go off-cycle and enter
an ERAD pathway. Although used by many organisms, this
mechanism is absent in yeast due to the lack of GT.
Even if the calnexin cycle is not universally conserved,
current evidence indicate that all eukaryotes have adapted
N-linked glycans for use in ERAD. For example, eliminating
the N-linked glycosylation sites of CPY* disrupted its degra-
dation in yeast cells (Knop et al., 1996). Although their role in
ERAD was unclear, it was suggested that the carbohydrates
were needed to maintain substrate conformations favorable for
ERAD. A different view emerged from genetic and pharmaco-
logical studies that assessed the effects of compromised carbo-
hydrate processing. The trimming of protein-linked Glc
 
3
 
Man
 
9
 
-
GlcNAc
 
2
 
 core carbohydrate(s) to the Man
 
8
 
GlcNAc
 
2
 
 form
(Glc, glucose; Man, mannose; GlcNAc, 
 
N
 
-acetylglucosamine)
was shown to be required for efficient substrate degradation
(Jakob et al., 1998; Tokunaga et al., 2000). This led to the
proposal that N-linked glycans can function as signals for
targeting ERAD substrates. The failure of Man
 
9
 
GlcNAc
 
2
 
,
Man
 
7
 
GlcNAc
 
2
 
, and Man
 
6
 
GlcNAc
 
2
 
 glycoforms to substitute for
Man
 
8
 
GlcNAc
 
2
 
 implied a degree of specificity expected of a
ligand–receptor interaction (Jakob et al., 1998). This model is
particularly appealing because the crucial mannose trimming
step was found to be much slower than the preceding process-
Figure 5. Degradation of the misfolded protein PrA*
requires a single NH2-terminal glycan. (A) Schematic rep-
resentation of PrA* and glycosylation site mutant deriva-
tives. Asparagines modified by glycosylation at positions
107 and 308 are indicated with A and B, respectively.
Lower case designations indicate mutant sites. (B) Cells
expressing PrA*, aB-PrA*, or Ab-PrA* were pulse labeled
for 10 min with [
35S]methionine/cysteine. Proteins were
immunoprecipitated from detergent lysates using poly-
clonal anti-PrA antibodies, mock treated ( ) or treated
( ) with Endo H, and resolved by SDS-PAGE. Positions of
PrA*,  1 PrA*, and deglycosylated PrA* are indicated.
(C) Wild-type cells expressing PrA*, aB-PrA*, or Ab-PrA*
were analyzed by pulse-chase analysis as in Fig. 1 E. The
data reflect two independent experiments with the SD of
the mean indicated. 
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ing steps. This led to the idea of a mannosidase I–dependent
mechanism that provides newly synthesized proteins a fixed
window of time for folding. Should the protein remain un-
folded by the time the enzyme acts, a lectin receptor was hy-
pothesized that targets Man
 
8
 
GlcNAc
 
2
 
-containing substrates to
ERAD (Jakob et al., 1998).
The discovery of an ER lectin-like protein required for
ERAD provided support for the proposed mechanism. Known
variously as Htm1p1, Mnl1p, or EDEM, the results of four in-
dependent groups indicate that glycoprotein substrates are di-
rected into ERAD by way of this membrane bound factor
(Hosokawa et al., 2001; Jakob et al., 2001; Nakatsukasa et al.,
2001; Molinari et al., 2003; Oda et al., 2003). The genetic ex-
periments that showed the importance of Man
 
8
 
GlcNAc
 
2
 
 would
also suggest that Htm1/Mnl1p plays a role in recognizing the
glycan (Jakob et al., 1998). Even as the Htm1p/Mnl1p/EDEM
lectin filled a gap in the model, other important questions re-
mained. Most importantly, how can substrates be distinguished
by this mechanism when properly folded glycoproteins also
bear Man
 
8
 
GlcNAc
 
2
 
 (Gemmill and Trimble, 1999)? The discov-
ery that ERAD glycan determinants are constrained to single,
specific sites helps address the conundrum.
The preference for specific carbohydrates reveals new in-
sight into how substrates are recognized by the glycan-depen-
dent ERAD system. The simple explanation of a general posi-
tional constraint along any polypeptide chain was ruled out
because respective signals were found in different positions
within PrA* and CPY*. This finding, together with the inability
of other glycans to substitute, suggest that a yet uncharacter-
ized component of the signal is located somewhere along the
polypeptide chain. Either of two scenarios could account for
how the determinant would act. In one, it directs modifications
to specific glycans much like the enzyme UDP-GlcNAc/lyso-
somal enzyme 
 
N
 
-acetlyglucosamine-1-phosphotransferase that
participates in the addition of mannose 6-phosphate to prelyso-
somal hydrolases (Baranski et al., 1990). The modified glycan
Figure 6. The ER lectin Htm1p/Mnl1p mediates PrA*
degradation through the NH2-terminal glycan. Wild-type
or  htm1/mnl1 cells expressing PrA* (A), Ab-PrA* (B), or
aB-PrA* (C) were analyzed by pulse-chase analysis. The
data reflect two independent experiments with the SD of
the mean indicated.JCB • VOLUME 169 • NUMBER 1 • 2005 80
would then serve as the ligand for the lectin receptor. Recent ex-
periments from the Jakob group have ruled out this possibility.
In agreement with substrate requirements from their previous
genetic studies, direct analysis of CPY* glycans purified from
wild-type cells showed that they are primarily Man8GlcNAc2
(C. Jakob, ETH Switzerland, personal communication).
If CPY*’s four N-linked carbohydrates share the same
structure and yet only the COOH-terminal glycan can function
to signal ERAD, it can be deduced that the signal also contains
a specific peptide component. By extension, we propose a
model by which the lectin binds Man8GlcNAc2 carbohydrates
only in conjunction with a specific protein determinant in the
unfolded state. This would explain why only single, specific
glycans in CPY* and PrA* are used to target the substrates to
the ERAD pathway. This simple mechanism would provide the
means to distinguish folding proteins (Man9GlcNAc2/unfolded
determinant: no binding), folded proteins (Man8GlcNAc2/
folded determinant: no binding), and “misfolded” proteins
(Man8GlcNAc2/unfolded determinant: binding). Operationally,
the cell need not define “misfolded” in structural terms. Any
molecule exceeding its time limit to fold is simply degraded
whether it could eventually fold or not. In line with the pro-
posed mechanism, our preliminary studies have determined a
short peptide segment from CPY* that fulfills the criteria for
an additional determinant. It is required for lectin-mediated
ERAD and is functionally transposable to other parts of the
polypeptide (unpublished data).
This study shows that determinants for ER quality control
(sorting and retention) and ERAD (targeting and degradation)
can be modular in their function. In the Htm1/Mnl1p arm of
ERAD, single, specific carbohydrates are required to target
substrates for degradation but are dispensable for their recogni-
tion and retention as misfolded proteins (e.g., CPY 1, ABCd-
CPY*). As these substrates represent but a small fraction of all
classes of misfolded proteins, our understanding of ERQC/
ERAD determinants is far from complete. With the list of
ERQC/ERAD factors rapidly expanding, it has never been
more important to uncover the nature of their substrates to un-
derstand how aberrant proteins are sorted for degradation.
Materials and methods
Strains and antibodies
Saccharomyces cerevisiae strains used in this study are listed in Table I.
Anti-HA (HA.11) was purchased from Covance Research Products. Anti-
Kar2p and anti-Sec61p antibodies were provided by P. Walter (University
of California, San Francisco, San Francisco, CA). Anti-PrA antiserum was
a gift from B. Jones (Carnegie Mellon, University, Pittsburgh, PA).
Plasmids used in this study
CPY* and CPY 1 expression vectors. Plasmids used in this study are listed
in Table II. Plasmids were constructed using standard cloning protocols.
pDN436, containing the gene for HA epitope-tagged CPY* was de-
scribed previously (Ng et al., 1990). pES57, carrying the CPY 1 variant
that lacks amino acids 369–522 of CPY was constructed in several steps.
The HA tag encoded in the reverse primer was introduced into PRC1 as a
COOH-terminal 0.6-kb fragment by PCR amplification and digested with
XbaI and BglI. A 1.1-kb PRC1 NH2-terminal fragment was purified as AccI
(end blunted by T4 DNA polymerase) to BglI digest from plasmid pTS3
(provided by T. Stevens, University of Oregon, Eugene, OR). The two frag-
ments were ligated into pDN201 (Ng et al., 1996), creating plasmid
pDN301 (CPYHA driven by the strong constitutive promoter TDH3). A 1.1-
kb fragment was released from plasmid pDN301 by digesting with HpaI
and EcoRV, and was religated to create plasmid pES9 (CPY 1HA driven
by the TDH3 promoter). Plasmid pES57 (CPY 1HA driven by the endoge-
nous PRC1 promoter) was created by ligating a ClaI–NgoMIV fragment
from pTS3 with an NgoMIV–SalI fragment from pES9 into the ClaI–SalI
sites of pRS316.
PrA* expression vector. The PrA* expression vector, pES142
(LEU2 marked) was constructed by ligating BamHI–ScaI and SspI–EagI
fragments released from plasmid BX33 (provided by B. Jones, Carnegie
Table I. Strains used in this study
Strain Genotype Source
W303a MATa leu2-3, 112, his3-11, trp1-1, ura3-1, can1-100, ade2-1 P. Walter
ESY258 MATa, pDN436, W303 background Spear and Ng, 2003
ESY259 MATa, cue1::TRP1, pDN436, W303 background Spear and Ng, 2003
ESY262 MATa, pES57, W303 background This study
ESY263 MATa, cue1::TRP1, pES57, W303 background This study
ESY410 MATa, pES95, W303 background This study
ESY578 MATa, pES115, W303 background This study
ESY587 MATa, pES121, W303 background This study
ESY593 MATa, pES123, W303 background This study
ESY611 MATa, pES129, W303 background This study
ESY617 MATa, pES132, W303 background This study
ESY673 MATa, htm1::KANMX, pDN436, W303 background This study
ESY676 MATa, pES147, W303 background This study
ESY677 MATa, htm1::KANMX, pES147, W303 background This study
ESY661 MATa, pep4::HIS3, pES163, W303 background This study
ESY665 MATa, pep4::HIS3, pES159, W303 background This study
ESY669 MATa, pep4::HIS3, pES170, W303 background This study
ESY708 MATa, pep4::HIS3, htm1::KANMX, pES163, W303 background This study
ESY709 MATa, pep4::HIS3, htm1::KANMX, pES159, W303 background This study
ESY710 MATa, pep4::HIS3, htm1::KANMX, pES170, W303 background This study
ESY714 MATa, leu2-3,112, his3-11::HIS3-UPRE-LacZ, trp1-1, ura3-1, can1-100, ade2-1, pDN437 This study
ESY715 MATa, leu2-3,112, his3-11::HIS3-UPRE-LacZ, trp1-1, ura3-1, can1-100, ade2-1, pDN436 This study
ESY721 MATa, leu2-3,112, his3-11::HIS3-UPRE-LacZ, trp1-1, ura3-1, can1-100, ade2-1, pES57 This studyERAD GLYCAN SIGNALS • SPEAR AND NG 81
Mellon University; Woolford et al., 1986) into the BamHI–EagI sites of
pRS315 (Sikorski and Hieter, 1989). A URA3 marked version, pES163,
was created by subcloning a NotI–XhoI fragment from pES142 into
pRS316.
Site-directed mutagenesis of CPY* and CPY 1. Site-directed muta-
genesis was performed using a PCR-based approach as described previ-
ously (Ng et al., 1996). Primers used for site-directed mutagenesis are
listed in Table III. All mutants were confirmed by DNA sequence analysis
performed by the Penn State DNA sequence core facility.
Cell labeling and immunoprecipitations
Metabolic pulse-chase analysis and immunoprecipitations were performed
as described previously (Vashist et al., 2001). Immunoprecipitates in Fig. 6
were treated with 300 U endoglysosidase H (New England Biolabs, Inc.)
to aid in the quantification of hyperglycosylated PrA* species.
Indirect Immunofluorescence
Indirect immunofluorescence experiments were performed as described
previously (Spear and Ng, 2003). Polyclonal rabbit anti-Kar2p and
HA.11 mAb (Covance Inc.) were used as primary antibodies and Alexa
Fluor 488 goat anti–rabbit and Alexa Fluor 546 goat anti–mouse (Molec-
ular Probes, Inc.) were used as secondary antibodies. Formaldehyde-fixed
cells were visualized using an Axioplan epifluorescence microscope (Carl
Zeiss MicroImaging, Inc.) with a Plan-Neofluar 100  objective (1.3 NA;
Carl Zeiss MicroImaging, Inc.) and immersion oil (Carl Zeiss MicroImag-
ing, Inc.). Image acquisition was performed using a SPOT 2 cooled CCD
camera using SPOT v. 3.5.5 software (Diagnostic Instruments, Inc.). Im-
ages were archived and converted to gray scale using Adobe Photoshop
4.0 (Adobe Systems).
Analysis of protein aggregates
Wild-type cells expressing CPY* (pDN436) or CPY 1 (pES57) were
grown in synthetic complete media supplemented with 2% glucose and
lacking leucine and uracil, respectively, to logarithmic phase. Control
 ire1 cells containing the GAL-CPY* gene (plasmid pES67; Spear and
Ng, 2003) were grown to logarithmic phase in synthetic complete contain-
ing 3% raffinose and 50  g/ml myo-inositol. CPY* overexpression was in-
duced for 7 h by the addition of galactose to 2%. Cells (5.0 OD600 units)
were collected by centrifugation and washed once with ice-cold water.
The cell pellet was resuspended in 500  l TNE (50 mM Tris, pH 7.4, 150
mM NaCl, 5 mM EDTA) containing protease inhibitor cocktail (Sigma-
Aldrich) and 1 mM PMSF, and transferred to a 1.5-ml screw-cap tube on ice.
Zirconium beads (0.4 ml of 0.5-mm diam) were added and cells were ho-
mogenized using a vortex mixer at full speed for 1 min, followed by 1 min
on ice. This cycle was repeated 8–10 times in the cold. The lysate was
cleared by centrifugation at 750 g for 5 min and repeated. Triton X-100
was added to 1% vol/vol and incubated for 5 min at RT. A 50  l portion
(T) was saved before ultracentrifugation at 100,000 g for 15 min at 4 C.
The supernatant (S) was removed and the pellet was resuspended in 450
 l 3% SDS, 50 mM Tris, pH 7.5, and incubated at 100 C for 5 min. Total
(T), supernatant (S) and pellet (P) fractions were resolved by SDS-PAGE,
transferred to nitrocellulose, and probed using specific antisera (1:10,000
anti-HA; 1:5,000 anti-Sec61) and HRP-conjugated secondary antibodies.
Proteins were visualized by ECL (Pierce Chemical Co.).
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Table II. Plasmids used in this study
Plasmid Protein Primers used Vector Source
pDN436 CPY*   pRS315 Ng et al., 2000
pDN437 CPY   pRS315 Ng et al., 2000
pES115 K(9)R-CPY* N325, N326, N335,
N336, N337, N338,
N435, N436, N437,
N438, N439, N440
pRS315 This study
pES129 aBCD-CPY* N491, N492 pRS315 This study
pES121 AbCD-CPY* N493, N494 pRS315 This study
pES123 ABcD-CPY* N495, N496 pRS315 This study
pES132 ABCd-CPY* N441, N442 pRS315 This study
pES147 abcD-CPY* N493, N494 pRS316 This study
pES57 CPY 1   pRS316 This study
pES95 R(3)K-CPY 1 N339, N340 pRS315 This study
pES163 PrA*   pRS316 This study
pES159 aB-PrA* N527, N528 pRS316 This study
pES170 Ab-PrA* N537, N538 pRS316 This study
Table III. Oligonucleotide primers used in this study
Primer Mutation Sequence (5  → 3 )
N323 R361K CPY 1 gccggtcttttggtaaggagccaa
N324 R364K CPY 1 aagaacgtttacgataacgaatgg
N325 K493R CPY* gtaggatctgacttcaccagcgac
N326 K496R CPY* agacacttcacctatttgagagtc
N335 K448R CPY* acagatgaaatctctatcgcctgc
N336 K458R CPY* aactggttgggtaatcgggcgtgg
N337 K467R CPY* ttcgtcgtaccgccatggcaagac
N338 K476R CPY* gaatttgcaagccaacgagtacgt
N339 R276K CPY 1 gtccttgtgagacaaaatttcaga
N340 R276K CPY 1 aaaaacttcaacttaacctccgtc
N435 K371R CPY* cctgatatcgtaaacgtttctgcc
N436 K371R CPY* agagattgtgaaggtggcaatttg
N437 K396R CPY* gacgtagtcctggtttaagtagtc
N438 K396R CPY* agagaagctgtcggtgcggaggtt
N439 K425R CPY* catccaatcacccgcaaacaggaa
N440 K425R CPY* agaccttaccacaccgccgtaaca
N441 N479Q CPY* acgtactttttggcttgcaaattc
N442 N479Q CPY* cagtggactgcttctatcaccgac
N491 N124Q CPY* tgggtcaatgcccaggattttagg
N492 N124Q CPY* caggtcacacagtacacgggttac
N493 N198Q CPY* gctgttccaagagtaagggttccc
N494 N198Q CPY* caggccaccgtgatcttccttgac
N495 N279Q CPY* gaagtttctgtccttgtgagacaa
N496 N279Q CPY* cagttaacctccgtcttgatcgga
N527 N107Q PrA* agctttgtagcttgatgaagcttc
N528 N107Q PrA* cagggtactgaatttgccattcaa
N537 N308Q PrA* attgaagttgaaaattagat
N538 N308Q PrA* ggctaccagttcactattggJCB • VOLUME 169 • NUMBER 1 • 2005 82
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